Summary
The analysis of 08:00–16:00 (0–8) hour urine collections following oral S-carboxymethyl-L-cysteine administration of 750 mg to 30 individuals identified S-carboxymethyl-L-cysteine, S-carboxymethyl-L-cysteine S-oxide, S-methyl-L-cysteine and S-methyl-L-cysteine S-oxide as the major urinary drug related compounds. No S-(carboxymethylthio)-L-cysteine mixed disulphide metabolite was found in the 08:00–16:00 hour urine collection but the metabolite was detected in the 16:00–00:00 (8–16) hour urune collection by paper chromatography, TLC and HPLC. The production of the S-oxide metabolites 08:00–16:00 hour urine collection) and the mixed disulphide metabolite (16:00–00:00 hour urine collection) were both shown to be biomodally distributed. A significant linear correlation of the S-oxides recovered following 08:00–16:00 hour urine collection as analysed by paper chromatography, TLC and HPLC is reported.
Similar content being viewed by others
References
A. Quevauviller, H. Yungoc, S. Garcet, L. Lakah, Therapie22, 485 (1967).
M. Jouille, H. Vungoc, G. Maillard, L. Laksh, P. Muller, Chem. Abstr.75, 9880 (1971).
S. C. Mitchell, R. H. Waring, Pharmacol. Therap.43, 237 (1989).
B. Staffeldt, J. Brockmoller, I. Roots, J. Chromatogr.571, 133 (1991).
J. Brockmoller, Z. J. Simane, I. Roots, Drug Metab. Drug Int.6, 447 (1988).
Berk Pharmaceuticals Limited. In: Monography on S-carboxymethylcysteine (Guildford, Surrey, England, 1973) p. 19.
E. Brandt, R. J. Block, B. Kassell, G. F. Cahill, Pro. Soc. Exp. Biol. Med.35, 501 (1936).
F. R. Blood, H. B. Lewis, J. Biol. Chem.139, 407 (1941).
F. Binkley, J. Biol. Chem.,182, 273 (1950).
W. R. Maynard, R. B. Bruce, G. G. Fox, J. Pharm. Sci.67, 1753 (1978).
L. B. Turnbull, L. Teng, J. M. Pitts, E. M. Pinchbeck, P. B. Bruce, Xenobiotica8, 621 (1978).
U. Hofmann, M. Eichelbaum, S. Seefried, C. O. Meese, Drug Metab. Disp.19, 222 (1991).
C. O. Meese, C. Fischer, A. Kupfer, H. Wisser, M. Eichelbaum, Biochem. Pharmacol.42, R13 (1991).
R. H. Waring, S. C. Mitchell, Drug Metab. Dispo.10, 61 (1982).
R. H. Waring, S. C. Mitchell, R. R. Shan, Xenobiotica,13, 311 (1983).
S. C. Mitchell, R. H. Waring, C. S. Haley, J. R. Idle, R. L. Smith, Brit. J. Clin. Pharmacol.18, 507 (1984).
S. A. McFadden, Toxicology111, 43 (1996).
P. Emery, C. S. Panayi, G. Huston, K. I. Welsh, S. C. Mitchell, R. R. Shah, J. R. Idle, R. L. Smith, R. H. Waring, J. Rheumatol.11, 626 (1984).
R. Ayesh, S. C. Mitchell, R. H. Waring, R. H. Withrington, M. H. Seifert, R. L. Smith, Br. J. Rheumatol.26, 197 (1987).
P. Emery, H. Bradley, A. Gough, V. Arthur, R. Jubb, R. Waring, Ann. Rheum. Dis.51, 318 (1992).
A. B. Olomu, C. R. Vickers, R. H. Waring, D. Clements, C. Babbs, T. W. Warnes, E. Elias, New Engl. J. of Med.318, 1089 (1988).
G. B. Steventon, R. H. Waring, A. C. Williams, H. S. Pall, D. Adams, LancetII, 644 (1988).
G. B. Steventon, M. T. E. Heafield, R. H. Waring, A. C. Williams, Neurology39, 883 (1989).
G. B. Steventon, M. T. E. Heafield, S. Sturman, R. H. Waring, A. C. Williams, Neurology40, 1095 (1990).
D. A. Price-Evans, In: Genetic factors in drug therapy: Clinical and Molecular Pharmacogenetics, Cambridge University Press, Cambridge (1993), p. 371.
A. Kupfer, F. Gerber, E. Manser, I. Turner, J. R. Idle, Naunyn-Schmiedeberg's Arch. Pharmacol.343, R10 (1991).
W. L. Gregory, O. F. W. James, I. Turner, c. O. Meese, J. R. Idle, Pharmacogenetics3, 270 (1993).
S. P. James, D. A. Jeffrey, R. H. Waring, P. B. Wood, Biochem. J.109, 727 (1968).
C. O. Meese, D. Specht, U. Hofmann, Arch. Pharm. (Weinheim)322, 957 (1990).
A. Schobler H. Grafje, Leibergs Ann. of Chem.617, 71 (1958).
C. O. Meese, Arch. Pharm. (Weinheim)320, 473 (1987).
E. A. Barnsley, A. E. R. Thompson, L. Young, Biochem. J.90, 588 (1964).
A. Kupfer, J. R. Idle, Lancet335, 1107 (1990).
C. S. Haley, R. H. Waring, S. C. Mitchell, R. R. Shah, J. R. Idle, R. L. Smith, Xenobiotica15, 445 (1985).
R. Ayesh, S. C. Mitchell, R. H. Waring, R. L. Smith, Br. J. Clin. Pharmacol.25, 664P (1988).
R. G. Watson, A. Olomu, D. Clements, R. H. Waring, S. C. Mitchell, E. Elias, Hepatology7, 72 (1988).
R. H. Waring, S. C. Mitchell, Lancet335, 1527 (1990).
J. Brockmoller, B. Staffeldt, I. Roots, Eur. J. Clin. Pharmacol.40, 387 (1991).
A. Kupfer, F. Gerber, E. Manser, W. Gregory, C. O. Meese, J. R. Idle, Experientia47, A29 (1991b).
C. O. Meese, D. Specht, E. D. Ratg, M. Eichelbaum, H. Wisser, Fres. J. Anal. Chem.346, 837 (1993).
G. B. Steventon, In: Biological interactions of sulphur compounds. (S. C. Mitchell, Ed.), Taylor & Francis, London (1996), p. 77.
S. C. Mitchell, R. H. Waring, G. B. Steventon, In: Pharmacogenetics of Drug Metabolism (W. Kalow, Ed.), Pergamon Press, New York (1992), p. 367.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Steventon, G.B. A methodological and metabolite identification study of the metabolism of S-carboxymethyl-L-cysteine in man. Chromatographia 48, 561–568 (1998). https://doi.org/10.1007/BF02466650
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02466650